Protransit, Inc.

Omaha, NE

UEI
F32QSKPPN192
CAGE
7ALD8
Primary NAICS
541713 Research and Development in Nanotechnology
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
SAM.gov registration date
Physical address
16514 L St, Omaha, NE 68135, USA
Website
protransitnanotherapy.com
Founded
2013
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
A novel antioxidant delivery system, pro-NP?, for protection against UV-related skin cancer R43AR078581 National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH) $783,450
Antioxidant enzyme-loaded pro-NP for treatment of TBI. R41NS119082 National Institute of Neurological Disorders and Stroke (NIH) $259,938

Quick answers

Is Protransit, Inc. registered in SAM.gov?

Yes. Protransit, Inc.'s SAM.gov registration is active through September 1, 2027.

What is Protransit, Inc.'s most recent federal award?

Protransit, Inc.'s most recent federal grant award is A novel antioxidant delivery system, pro-NP?, for protection against UV-related skin cancer (R43AR078581), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH), on June 1, 2021.

On GovTribe

See Protransit, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login